Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients

David Loven*, Einat Be'ery, Rinat Yerushalmi, Claude Koren, Aaron Sulkes, Idit Lavi, Yuval Shaked, Eyal Fenig

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology